AMZNprintsminutestrendsdividendsdrawdownsP/E 28.4macronarrativesvolatilitybuybackssentiment+0.8%marginsMSFTPMI 52.1momentumdividendsflowsPMI 52.1digeststhreadsvolatilityearnings callsvolumesβ 1.24breakoutsnewsflow2s10sliquidityheadlines−1.2%breakoutsnoiseGOOGLbuybacksrevisionstrendsPMI 52.1briefstickersnoiseGDPsentimentchattertranscriptsGOOGLsentimentvolatilitybuybacksMSFTwhispersMETAsessionsyield curves13FfuturesdowngradesPMI 52.1headlinesthe tapeflowsdowngradesfutures+0.8%earnings callstranscriptsclosesgammacatalystsrevisionsvolatilitysentimentchatter+2.41%earnings callssentimentfilingstrends10y 4.21%cyclesbuybackswiresspx 0dtewhisperstickersQ3trendsnewsflowearnings callsWTI 78.2sentimentnoisethreadsrumorsnarrativesFOMCconsensusestimatesmomentumYoY +18%tickersmomentumprintsβ 1.24revisions

momentumheadlines52w hipositioning2s10sfilingstrendsprintstrendsmacrocyclesnoise2s10smacroQ3narrativesheadlinesflowscyclesnarrativesspreadstranscriptsdowngradesupgradeswhisperswhispersminutesthe tapeNDXfuturesminutesyield curves52w hithe tapeFOMCcatalystsbriefsthe tapeNVDAguidancetrends52w hidrawdowns2s10swhispersmomentumdrawdownsbuybacks

PCEliquiditysentimentbreakoutsdowngradesP/E 28.4threadsAAPLSPXvolatilityNDXflowscyclesliquidityestimatesEPS 4.12

ITGR · NYSE · Medical - Devices

Integer (ITGR)

Develops and manufactures cardiac, vascular, and neuromodulation devices for medical-technology companies.

$126.33

After hours−0.05 (−0.04%)

At close$126.38(−0.00%)

In millions of USD, except per-share figures

In millions	Q3 FY23Sep 2023	Q4 FY23Dec 2023	Q1 FY24Mar 2024	Q2 FY24Jun 2024	Q3 FY24Sep 2024	Q4 FY24Dec 2024	Q1 FY25Mar 2025	Q2 FY25Jun 2025	Q3 FY25Sep 2025	Q4 FY25Dec 2025	Q1 FY26Apr 2026	Q2 FY26Jul 2026
Revenue	397	405	408	428	431	449	436	473	467	471	440	464
Cost of revenue	291	294	299	310	314	333	330	366	358	365	330	351
Gross profit	105	110	109	118	117	117	106	107	108	106	110	113
	57	67	70	63	59	60	54	55	55	55	74	78
Research & development	14	13	15	16	12	11	14	14	11	10	16	11
Selling, general & administrative	41	45	46	46	44	47	40	40	38	44	55	58
Other expenses	1	8	8	2	3	2	0	0	6	1	3	9
Operating income	49	44	39	54	58	57	52	53	54	51	35	35
	−16	−14	−14	−14	−15	−18	−65	−7	−8	−4	−15	−11
Interest income	0	0	0	0	0	1	0	0	0	0	0	0
Interest expense	11	13	14	15	15	12	14	10	9	9	10	10
Other non-operating income	−1	−9	−8	−2	−3	−2	51	−3	−2	−5	5	1
Income before tax	33	30	25	40	43	39	−13	46	46	47	20	23
Income tax expense	5	3	4	9	7	6	9	9	6	−2	4	0
Net income from continuing operations	28	27	21	31	36	33	−22	37	40	49	17	24
Discontinued operations	−1	0	0	0	−1	0	0	0	0	0	0	0
Net income	27	26	21	31	35	33	−23	37	40	49	17	24
EPS, basic	$0.82	$0.79	$0.61	$0.93	$1.05	$0.97	−$0.66	$1.06	$1.13	$1.39	$0.48	$0.69
EPS, diluted	$0.81	$0.78	$0.59	$0.88	$0.99	$0.90	−$0.66	$1.04	$1.11	$1.38	$0.48	$0.69
Weighted average shares, basic	33	33	33	34	34	34	34	35	35	35	34	34
Weighted average shares, diluted	34	34	35	36	36	36	34	36	36	35	34	34
EBITDA	75	76	73	84	90	86	31	88	88	92	65	68
Depreciation & amortization	25	24	26	27	29	28	30	32	33	36	35	35
EBIT	50	52	47	56	61	59	1	55	55	56	30	33